Ten Years Later: Jesse Gelsinger’s Death and Human Subjects Protection
By Osagie K. Obasogie,
Bioethics Forum
| 10. 22. 2009
Last month marked the tenth anniversary of Jesse Gelsinger's death. While perhaps not quite a household name, Gelsinger is vividly remembered among many medical researchers. His death during a gene therapy clinical trial in September 1999 rocked the field like nothing else since the Tuskegee experiments. But sadly, the questionable research practices that led to Gelsinger's death have only become more troublesome in the past decade. Indeed, protections for clinical trial participants seem to be waning at the very moment they are needed most.
Gelsinger suffered from orinthine trascarbamlase deficiency (OTCD), a rare metabolic disorder that prevents the body from breaking down ammonia. Many children with OTCD die at a young age, but Gelsinger had a mild version and led a fairly normal life through medicine and a special diet. Since a single-gene defect is responsible for OTCD, researchers considered it a prime candidate for gene therapy, a still-experimental treatment that attempts to replace defective genes with normal ones.
Gene therapy was the embryonic stem cell research of the 1990s; its ability to cure was thought to be boundless and... see more
Related Articles
By Kathryn Paige Harden et al., The New York Review | 05.25.2022
In response to:
Why Biology Is Not Destiny from the April 21, 2022 issue
To the Editors:
Marcus Feldman and Jessica Riskin did not like my book. Or rather, they did not like a book called The Genetic Lottery...
By Hannah Devlin, The Guardian | 05.20.2022
The fertility watchdog is considering whether to recommend scrapping anonymity for future sperm and egg donors as part of an expected overhaul of UK fertility laws.
Peter Thompson, the chief executive of the Human Fertilisation and Embryology Authority (HFEA), said...
By Megan Molteni, STAT | 05.23.2022
Photo by Colin Lloyd on Unsplash
The 18-year-old gunman suspected of carrying out a racist attack that killed 10 and injured three people in Buffalo, N.Y., last weekend left no questions about why he drove 200 miles to a supermarket...
By Jonathan Grinstein, Neo.Life | 05.19.2022
The real-life creation of human-animal hybrids, which is on the verge of going from hypothesis to reality, has been the subject of ongoing debate since the dawn of genetic engineering. But recent advances have made these creatures of dreams (or...